Photodynamic therapy for leishmaniasis: recent advances and future trends
dc.authorid | Ali Zarrabi / 0000-0003-0391-1769 | en_US |
dc.authorscopusid | Ali Zarrabi / 23483174100 | |
dc.authorwosid | Ali Zarrabi / U-2602-2019 | |
dc.contributor.author | Varzandeh, Mohammad | |
dc.contributor.author | Mohammadinejad, Reza | |
dc.contributor.author | Esmaeilzadeh-Salestani, Keyvan | |
dc.contributor.author | Dehshahri, Ali | |
dc.contributor.author | Zarrabi, Ali | |
dc.contributor.author | Aghaei-Afshar, Abbas | |
dc.date.accessioned | 2021-11-15T06:01:48Z | |
dc.date.available | 2021-11-15T06:01:48Z | |
dc.date.issued | 2021 | en_US |
dc.department | İstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü | en_US |
dc.description.abstract | Leishmaniasis has infected more than 12 million people worldwide. The neglected tropical disease causing 20,000-30,000 deaths per year determined as a global health problem. The emergence of resistant parasites and serious side effects of the conventional therapies has led to the search for less toxic and non-invasive alternative treatments. Photodynamic therapy is a promising therapeutic strategy to produce reactive oxygen species for the treatment of leishmaniasis. In this regard, natural and synthetic photosensitizers such as curcumin, hypericin, 5-aminolevulinic acid, phthalocyanines, phenothiazines, porphyrins, chlorins and nanoparticles have been applied. In this review, the recent advances on using photodynamic therapy for treating Leishmania species have been reviewed. | en_US |
dc.identifier.citation | Varzandeh, M., Mohammadinejad, R., Esmaeilzadeh-Salestani, K., Dehshahri, A., Zarrabi, A., & Aghaei-Afshar, A. (2021). Photodynamic therapy for leishmaniasis: recent advances and future trends. Photodiagnosis and photodynamic therapy, 102609. Advance online publication. | en_US |
dc.identifier.doi | 10.1016/j.pdpdt.2021.102609 | en_US |
dc.identifier.pmid | 34728420 | en_US |
dc.identifier.scopus | 2-s2.0-85118891276 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.pdpdt.2021.102609 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2232 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000719780700007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Zarrabi, Ali | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science | en_US |
dc.relation.ispartof | Photodiagnosis Photodyn Ther. | en_US |
dc.relation.publicationcategory | DiÄŸer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Leishmania | en_US |
dc.subject | Photodynamic Therapy | en_US |
dc.subject | Leishmaniasis | en_US |
dc.subject | Nanoparticles | en_US |
dc.subject | Parasites | en_US |
dc.subject | Photosensitizers | en_US |
dc.title | Photodynamic therapy for leishmaniasis: recent advances and future trends | en_US |
dc.type | Review Article | en_US |